In silico neuroprotective properties of volatile constituents of grape (Vitis vinifera L.) seed extract against Parkinson's disease
by Venkatramanan Varadharajan
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 14, No. 2, 2021

Abstract: Aggregation of α-synuclein is one of the significant factors in the pathogenesis of Parkinson's disease. Many natural extracts demonstrate neuroprotective activity against PD by inhibiting α-synuclein aggregation. In India, the grape extract is traditionally used as a brain tonic to boost memory power. Hence in this study, the neuroprotective activity of grape seed extract against Parkinson's disease under in silico conditions was investigated. Molecular docking studies indicated that volatile constituents of ethanolic extract of grape seed could bind to both C-terminal and N-terminal regions of α-synuclein with more preference towards the formation of hydrogen bonds than hydrophobic interactions. Also, the compounds most commonly interacted with the residues Val40, Lys43 and Lys45 of N-terminal to form both hydrogen bonds and hydrophobic interactions. Among the compounds studied, Dasycarpidan-1-methanol, acetate (ester) molecule showed superior binding affinity, Blood-Brain Barrier penetration, drug-likeness and lead-likeness properties.

Online publication date: Wed, 16-Jun-2021

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com